| Download the amazing global Makindo app: ✅ Means NICE/National Guidelines 2026 compliant Android | Apple | |
|---|---|
| MEDICAL DISCLAIMER: Educational use only. Not for diagnosis or management. See below for full disclaimer. |
Alpha-gal syndrome is an unusual form of food allergy in which patients develop an IgE-mediated reaction to galactose-α-1,3-galactose, usually shortened to alpha-gal. Alpha-gal is a carbohydrate found in the tissues of most non-primate mammals. Unlike conventional food allergy, reactions are often delayed for several hours after eating mammalian meat.
The condition is strongly associated with tick bites. Tick saliva appears to stimulate production of IgE antibodies against alpha-gal. Subsequent exposure to alpha-gal in food or other mammalian-derived products may then trigger an allergic reaction. In the United States, the lone star tick is particularly associated with alpha-gal syndrome. Other tick species have been implicated in Europe, Australia and elsewhere. The condition can therefore occur in the UK, although it is much less commonly recognised than in some parts of the United States.
Poultry, fish and seafood do not contain alpha-gal and are generally tolerated. Dairy products contain smaller amounts of alpha-gal and many patients can tolerate milk and dairy, although patients with more severe disease may react to them.
Most IgE-mediated food allergies cause symptoms within minutes because allergenic proteins are absorbed relatively quickly. Alpha-gal is mainly associated with glycolipids and other lipid-containing molecules. These are processed and absorbed more slowly through the gastrointestinal tract and lymphatic system, which probably explains why reactions frequently occur 2 to 6 hours after eating. This delay is an important diagnostic clue. A patient may eat steak in the evening and develop urticaria, abdominal symptoms or anaphylaxis during the night, making the association with food less obvious.
Some patients predominantly develop gastrointestinal symptoms without obvious urticaria or respiratory symptoms. This can lead to investigation for gastrointestinal disease before the allergic mechanism is recognised.
Consider alpha-gal syndrome in a patient with otherwise unexplained recurrent urticaria or anaphylaxis, particularly when episodes occur several hours after eating red meat. A history of tick bites or frequent exposure to wooded or rural environments strengthens the suspicion.
The amount of alpha-gal consumed is only one determinant of the reaction. Fatty meals may produce more significant reactions because lipid absorption is important in transporting alpha-gal-containing molecules. Alcohol, exercise and NSAIDs may also act as cofactors and lower the threshold for a reaction.
The diagnosis is based on the characteristic clinical history together with evidence of IgE sensitisation to alpha-gal.
A positive alpha-gal IgE test indicates sensitisation but must be interpreted alongside the clinical history. Some people may have detectable antibodies without clinically significant reactions.
The main treatment is avoidance of foods that trigger reactions. The degree of avoidance required varies between patients.
Anaphylaxis associated with alpha-gal syndrome is managed in exactly the same way as anaphylaxis from other causes. Intramuscular adrenaline is the first-line treatment.
Alpha-gal is also relevant to medicine because some pharmaceutical and biological products are derived from mammals. The clinical significance varies considerably between patients and between products.
These products should not automatically be withheld from every patient with alpha-gal syndrome. The clinical history, severity of previous reactions and the importance of the proposed treatment should be considered, with allergy specialist advice where necessary.
Cetuximab provides an important historical link to the discovery of alpha-gal allergy. Some patients developed severe immediate hypersensitivity reactions to their first cetuximab infusion. Investigators subsequently demonstrated that these patients already had IgE antibodies against alpha-gal present on the cetuximab molecule. This observation helped establish the association between tick exposure, alpha-gal sensitisation and mammalian meat allergy.
Alpha-gal IgE concentrations may gradually fall if further tick bites are avoided. Some patients eventually regain tolerance to mammalian meat, although this can take several years. Further tick bites may increase antibody levels again and lead to recurrence or worsening of reactions.